SEC Form 4 · accession 0001165527-17-000040
Vilacto Bio Inc. · VIBI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dana Gallovicova
Officer — CEO, CFO · Director · 10% Owner
Period of report
Feb 24, 2017
Accepted (ET)
Feb 28, 2017 · 10:16 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576724
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common voting | Feb 24, 2017 | S | 5,000,000 | $0.02 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.